Dr Steven G Bander, DO | |
217 N Harrison Ave Ste 109, Blanchard, OK 73010-6217 | |
(405) 888-8483 | |
(918) 803-4861 |
Full Name | Dr Steven G Bander |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 42 Years |
Location | 217 N Harrison Ave Ste 109, Blanchard, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578545026 | NPI | - | NPPES |
00AW60 | Other | TX | BCBS |
114033704 | Medicaid | TX | |
AW60 | Other | BCBS | |
080003644 | Other | RR MCR | |
114033703 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | G3129 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Peterson Healthcare Llc | 6103251988 | 3 |
News Archive
The WHO on Tuesday said it is ready to assist Japan with its emerging "nuclear emergency after some reactors were damaged by last week's deadly earthquake" and tsunami, Agence France-Presse reports.
BIO-key International, Inc., a leader in finger-based biometric identification and wireless public safety and a member of the Oracle® PartnerNetwork, is showcasing its fingerprint biometric solutions at the Oracle OpenWorld 2009 conference being held at the Moscone Center in San Francisco from October 11-15, 2009.
A new animal model of atherosclerosis has allowed researchers to identify a host of genes turned on or off during the initial stages of the process, before a plaque appears in the affected blood vessel.
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat diseases of poverty. The Phase 1 trial is taking place in Washington State, with a companion Phase 1 trial planned in India, an epicenter of the disease.
› Verified 9 days ago
Entity Name | Peterson Healthcare Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609414168 PECOS PAC ID: 6103251988 Enrollment ID: O20200124001837 |
News Archive
The WHO on Tuesday said it is ready to assist Japan with its emerging "nuclear emergency after some reactors were damaged by last week's deadly earthquake" and tsunami, Agence France-Presse reports.
BIO-key International, Inc., a leader in finger-based biometric identification and wireless public safety and a member of the Oracle® PartnerNetwork, is showcasing its fingerprint biometric solutions at the Oracle OpenWorld 2009 conference being held at the Moscone Center in San Francisco from October 11-15, 2009.
A new animal model of atherosclerosis has allowed researchers to identify a host of genes turned on or off during the initial stages of the process, before a plaque appears in the affected blood vessel.
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat diseases of poverty. The Phase 1 trial is taking place in Washington State, with a companion Phase 1 trial planned in India, an epicenter of the disease.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Steven G Bander, DO 2449 County Road 1370, Blanchard, OK 73010-4206 Ph: (214) 384-1631 | Dr Steven G Bander, DO 217 N Harrison Ave Ste 109, Blanchard, OK 73010-6217 Ph: (405) 888-8483 |
News Archive
The WHO on Tuesday said it is ready to assist Japan with its emerging "nuclear emergency after some reactors were damaged by last week's deadly earthquake" and tsunami, Agence France-Presse reports.
BIO-key International, Inc., a leader in finger-based biometric identification and wireless public safety and a member of the Oracle® PartnerNetwork, is showcasing its fingerprint biometric solutions at the Oracle OpenWorld 2009 conference being held at the Moscone Center in San Francisco from October 11-15, 2009.
A new animal model of atherosclerosis has allowed researchers to identify a host of genes turned on or off during the initial stages of the process, before a plaque appears in the affected blood vessel.
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat diseases of poverty. The Phase 1 trial is taking place in Washington State, with a companion Phase 1 trial planned in India, an epicenter of the disease.
› Verified 9 days ago
James Francis Swanson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2002 N Council Ave, Blanchard, OK 73010 Phone: 405-485-4701 Fax: 405-485-3747 | |
Kayeleigh Kelley Baskin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2002 N Council Ave, Blanchard, OK 73010 Phone: 405-485-4701 Fax: 405-485-3747 | |
Ryan Ray Turner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1019 N Council Ave, Suite 1, Blanchard, OK 73010 Phone: 405-515-0360 Fax: 405-307-5596 |